SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is surging amidst escalating Middle East tensions and concerns over restricted oil flows through the Strait of Hormuz, sparking community speculation on a prolonged energy shock versus an eventual price correction.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending due to escalating Middle East tensions, with Iranian strikes on oil infrastructure and the effective closure of the Strait of Hormuz fueling expectations of a massive oil price surge. The community is actively debating if this geopolitical risk premium signals a sustained energy rally or a fleeting market panic, impacting broader inflation concerns.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending due to its recent Q4 earnings report, which sparked polarized community debate following a headline revenue miss attributed to one-time accounting adjustments. While some investors express concern over revenue recognition, many view the reported strong annual growth, record cash balance, and new $25M share repurchase program as robust bullish indicators, labeling the stock an "absolute bargain" amid a perceived market overreaction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is generating intense anticipation around its pivotal Phase 3 REGAL trial results for GPS, an immunotherapy for AML, with community discussions highlighting potential for "curative outcomes" and a massive market opportunity, fueling widespread speculation of an imminent Big Pharma buyout as the CEO's recent communications are seen as highly bullish signals.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as its utility gains traction through major integrations with Sui and Cardano, alongside a notable partnership with the US Commerce Department to publish economic data on-chain. The community is buzzing about its position as a vital Real World Asset (RWA) oracle, often comparing its fundamental value against meme tokens, further fueled by its newly announced token buyback program.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility as escalating geopolitical tensions in the Middle East and mixed sentiment following recent semiconductor earnings reports drive sharp market swings, leading the community to intensely debate aggressive 'buy the dip' opportunities versus predictions of further downside.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending due to consistent inflows into its spot ETFs and favorable regulatory developments, such as Japan classifying it as a financial asset, signaling increased institutional interest. The community remains divided, with many actively accumulating during price dips in anticipation of a rally, while others voice strong skepticism regarding its underlying value and potential for dilution.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending following its definitive agreement to acquire Warner Bros. Discovery, a move viewed by bulls as creating a formidable global streaming and media giant under David Ellison's strategic vision, while bears raise significant concerns over the massive debt burden leading to recent credit downgrades.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending due to its strategic workforce reductions despite strong earnings, sparking community debate over efficiency versus weakness, while simultaneously making significant moves into cryptocurrency ETFs and custody services, signaling a bold pivot into digital assets amidst a recovering M&A market.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending as escalating Middle East tensions drive global oil prices higher, yet the community is actively discussing its puzzling lag behind surging crude and widely anticipating a significant catch-up rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royce & Associates LP Decreases Stock Holdings in Palvella Therapeutics, Inc. $PVLA

Royce & Associates LP reduced its holdings in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 33.6% in the third quarter, according to its most recent filing with the Securities & Exchange...

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Short Interest Update

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) saw a large growth in short interest in February. As of February 13th, there was short interest totaling 1,674,747 shares, a growth of...

Elaine Heron Acquires 2,400 Shares of Palvella Therapeutics (NASDAQ:PVLA) Stock

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) Director Elaine Heron purchased 2,400 shares of the business's stock in a transaction dated Friday, February 27th. The shares were acquired...

Palvella Therapeutics (NASDAQ:PVLA) Director Elaine Heron Purchases 2,400 Shares

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) Director Elaine Heron acquired 2,400 shares of the firm's stock in a transaction on Friday, February 27th. The stock was purchased at an...

Insider Buying: Palvella Therapeutics (NASDAQ:PVLA) Director Acquires 4,000 Shares of Stock

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) Director George Jenkins purchased 4,000 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The stock was...

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up After Analyst Upgrade

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up on Analyst Upgrade...

HC Wainwright Has Optimistic Outlook of PVLA FY2027 Earnings

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) - HC Wainwright boosted their FY2027 earnings estimates for shares of Palvella Therapeutics in a research note issued to investors on Tuesday...

What is Lifesci Capital's Estimate for PVLA FY2026 Earnings?

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) - Investment analysts at Lifesci Capital raised their FY2026 earnings estimates for Palvella Therapeutics in a research report issued on...

Palvella Therapeutics (NASDAQ:PVLA) Price Target Raised to $250.00 at Mizuho

Mizuho raised their price objective on Palvella Therapeutics from $205.00 to $250.00 and gave the stock an "outperform" rating in a research report on Wednesday...

BTIG Research Raises Palvella Therapeutics (NASDAQ:PVLA) Price Target to $215.00

BTIG Research increased their price objective on shares of Palvella Therapeutics from $192.00 to $215.00 and gave the company a "buy" rating in a research report on Wednesday...

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

PVLA
Palvella Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PVLA News

PVLAPalvella Therapeutics Inc